Media Coverage

Media Coverage

News featured in NuFFooDS Spectrum India

NuFFooDS Spectrum India, a leading B2B media platform in nutrition, nutraceuticals and dietary supplements, functional foods and beverages, ingredients space since 2013 has launched its first ranking special edition in February 2021. The survey looked at only the nutraceutical industry with companies specializing in vitamins/ minerals/nutrients (VMN). The companies (both MNCs and domestic players) were highlighted based on their achievements over the previous financial years.

With over 1000 companies actively involved in the business of manufacturing and selling nutraceutical products comprising VMN, the Indian nutrients market has registered a growth of 10.5 percent in 2019-20 to garner Rs. 23,893 crore against the previous year’s sales revenue of Rs. 21,616 crore. Indian companies contribute 66 percent of the total Nutra (vitamin/ minerals/ nutrients) industry while the remaining 34 percent comes from the MNCs. The Western region is dominating the nutraceutical industry as 71 percent of the companies are based in this region, followed by the Southern region, home to 21 percent of the nutraceutical companies.

Read more... 

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.